Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 7, 2006
The "pull-push" technique to deal with a redundant eustachian valve interfering with placement of a PFO occluderGianfranco Butera, Antonio Montinaro, Mario CarminatiJournal of the American College of Cardiology|August 7, 2010
Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trialGermano Di Sciascio, Giuseppe Patti, Vincenzo Pasceri, et al.Journal of the American College of Cardiology|August 1, 2009
Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized TrialGermano Di Sciascio, Giuseppe Patti, Vincenzo Pasceri, et al.European Heart Journal|April 6, 2010
Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trialGermano Di Sciascio, Giuseppe Patti, Vincenzo Pasceri, et al.Circulation|March 8, 2005
Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) studyGiuseppe Patti, Giuseppe Colonna, Vincenzo Pasceri, et al.The American Journal of Cardiology|May 3, 2011
Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trialGiuseppe Patti, Elisabetta Ricottini, Annunziata Nusca, et al.Journal of the American College of Cardiology|March 31, 2007
Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trialGiuseppe Patti, Vincenzo Pasceri, Giuseppe Colonna, et al.International Journal of Cardiology|August 12, 2008
Transradial access compared with femoral puncture closure devices in percutaneous coronary proceduresAlessandro Sciahbasi, Dionigi Fischetti, Amedeo Picciolo, et al.International Journal of Cardiology|April 30, 2005
Myocarditis with ST-Elevation Myocardial Infarction presentation in young man. A case series of 11 patientsMarcello Costantini, Cristina Tritto, Enrico Licci, et al.Journal of Neuro-Oncology|December 4, 2010
Retrospective protein expression and epigenetic inactivation studies of CDH1 in patients affected by low-grade gliomaPietro Ivo D'Urso, Oscar Fernando D'Urso, Carlo Storelli, et al.Pageof 2